Certest Lipids

Certest Press Release Image 1

Our partnership with Certest is advancing lipid-based delivery solutions through cutting-edge ionizable lipid technologies.

This collaboration allows us to develop innovative lipids that passively target the lungs, liver, and spleen, enhancing therapeutic precision and minimizing off-target effects. By combining Certest’s expertise with Avanti Research’s commitment to quality and innovation, we’re driving the future of targeted drug delivery.

Learn more about the partnership and its impact here.

    • BUY
      860798 - CP-LC-1067
    • BUY
      860799 - CP-LC-0729
    • BUY
      860800 - CP-LC-1421